{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:01:24Z","timestamp":1780034484061,"version":"3.53.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key R&D Program of China,Ministry of Science and Technology of the People\u2019s Republic of China","award":["2023YFC2411504"],"award-info":[{"award-number":["2023YFC2411504"]}]},{"name":"Peking Union Medical College Hospital Talent Cultivation Program","award":["No.UBJ04712"],"award-info":[{"award-number":["No.UBJ04712"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16020-3","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:16:54Z","timestamp":1776503814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of ultra-hypofractionated post-operative radiation therapy for breast cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhiyong","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"3","key":"16020_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"16020_CR2","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019;30(8):1194\u2013220.","journal-title":"Ann Oncol"},{"issue":"3","key":"16020_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","volume":"8","author":"BD Smith","year":"2018","unstructured":"Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8(3):145\u201352.","journal-title":"Pract Radiat Oncol"},{"issue":"9935","key":"16020_CR4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127\u201335.","journal-title":"Lancet"},{"issue":"2","key":"16020_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0360-3016(03)00579-0","volume":"57","author":"Y Lievens","year":"2003","unstructured":"Lievens Y, van den Bogaert W, Kesteloot K. Activity-based costing: a practical model for cost calculation in radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(2):522\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"16020_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","volume":"94","author":"T Whelan","year":"2002","unstructured":"Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94(15):1143\u201350.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"16020_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","volume":"75","author":"J Yarnold","year":"2005","unstructured":"Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005;75(1):9\u201317.","journal-title":"Radiother Oncol"},{"issue":"9618","key":"16020_CR8","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098\u2013107.","journal-title":"Lancet"},{"issue":"11","key":"16020_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086\u201394.","journal-title":"Lancet Oncol"},{"issue":"10237","key":"16020_CR10","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613\u201326.","journal-title":"Lancet"},{"issue":"28","key":"16020_CR11","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1200\/JCO.19.02750","volume":"38","author":"AM Brunt","year":"2020","unstructured":"Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A, et al. Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer. J Clin Oncol. 2020;38(28):3261\u201372.","journal-title":"J Clin Oncol"},{"issue":"1","key":"16020_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.radonc.2011.06.026","volume":"100","author":"RK Agrawal","year":"2011","unstructured":"Agrawal RK, Alhasso A, Barrett-Lee PJ, Bliss JM, Bliss P, Bloomfield D, et al. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015). Radiother Oncol. 2011;100(1):93\u2013100.","journal-title":"Radiother Oncol"},{"key":"16020_CR13","doi-asserted-by":"publisher","first-page":"103090","DOI":"10.1016\/j.critrevonc.2020.103090","volume":"156","author":"GN Marta","year":"2020","unstructured":"Marta GN, Coles C, Kaidar-Person O, Meattini I, Hijal T, Zissiadis Y, et al. The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review. Crit Rev Oncol Hematol. 2020;156:103090.","journal-title":"Crit Rev Oncol Hematol"},{"key":"16020_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"16020_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.breast.2020.12.009","volume":"55","author":"H Van Hulle","year":"2021","unstructured":"Van Hulle H, Vakaet V, Monten C, Deseyne P, Schoepen M, Colman C, et al. Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost. Breast. 2021;55:105\u201311.","journal-title":"Breast"},{"key":"16020_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","volume":"174","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Chatterjee S. HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis. Radiother Oncol. 2022;174:59\u201368.","journal-title":"Radiother Oncol"},{"key":"16020_CR17","doi-asserted-by":"crossref","unstructured":"Ivanov O, Milovan\u010dev A, Petrovi\u0107 B, Prvulovi\u0107 Bunovi\u0107 N, Li\u010dina J, Bojovi\u0107 M et al. Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic. Med (Kaunas). 2022;58(6):745.","DOI":"10.3390\/medicina58060745"},{"issue":"4","key":"16020_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ijrobp.2023.10.018","volume":"118","author":"BS Laughlin","year":"2024","unstructured":"Laughlin BS, Corbin KS, Toesca DAS, Thorpe CS, Golafshar MA, Pockaj B, et al. Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery. Int J Radiat Oncol Biol Phys. 2024;118(4):1049\u201359.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"16020_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s43046-025-00280-4","volume":"37","author":"A Magdy","year":"2025","unstructured":"Magdy A, Sadaka E, Abd El Ghani R, Ahmed T. Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy. J Egypt Natl Canc Inst. 2025;37(1):34.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"5","key":"16020_CR20","first-page":"282","volume":"59","author":"A Shahid","year":"2009","unstructured":"Shahid A, Athar MA, Asghar S, Zubairi T, Murad S, Yunas N. Post mastectomy adjuvant radiotherapy in breast cancer: a comparision of three hypofractionated protocols. J Pak Med Assoc. 2009;59(5):282\u20137.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"16020_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijrobp.2004.04.059","volume":"61","author":"C Ortholan","year":"2005","unstructured":"Ortholan C, Hannoun-L\u00e9vi J-M, Ferrero J-M, Largillier R, Courdi A. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiation Oncology*Biology*Physics. 2005;61(1):154\u201362.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"3","key":"16020_CR22","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.ijrobp.2012.10.021","volume":"85","author":"AE Dragun","year":"2013","unstructured":"Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, et al. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys. 2013;85(3):e123\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"16020_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.clbc.2014.12.011","volume":"15","author":"P Rovea","year":"2015","unstructured":"Rovea P, Fozza A, Franco P, De Colle C, Cannizzaro A, Di Dio A, et al. Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation. Clin Breast Cancer. 2015;15(4):270\u20136.","journal-title":"Clin Breast Cancer"},{"key":"16020_CR24","doi-asserted-by":"publisher","first-page":"8321871","DOI":"10.1155\/2018\/8321871","volume":"2018","author":"J Sanz","year":"2018","unstructured":"Sanz J, Zhao M, Rodr\u00edguez N, Granado R, Foro P, Reig A, et al. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int. 2018;2018:8321871.","journal-title":"Biomed Res Int"},{"issue":"5","key":"16020_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/tbj.13372","volume":"25","author":"LM Reboucas","year":"2019","unstructured":"Reboucas LM, Campos CS, D\u2019Amico GM, Lustosa AB, Fregnani JH. Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial. Breast J. 2019;25(5):953\u20137.","journal-title":"Breast J"},{"issue":"6","key":"16020_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.21873\/invivo.11694","volume":"33","author":"E Bonzano","year":"2019","unstructured":"Bonzano E, Belgioia L, Polizzi G, Siffredi G, Fregatti P, Friedman D, et al. Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence. Vivo. 2019;33(6):1985\u201392.","journal-title":"Vivo"},{"issue":"2","key":"16020_CR27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12094-020-02430-7","volume":"23","author":"M Zhao","year":"2021","unstructured":"Zhao M, Sanz J, Rodr\u00edguez N, Foro P, Reig A, Membrive I, et al. Weekly radiotherapy in elderly breast cancer patients: a comparison between two hypofractionation schedules. Clin Transl Oncol. 2021;23(2):372\u20137.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"16020_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijrobp.2021.06.026","volume":"112","author":"LB Reshko","year":"2022","unstructured":"Reshko LB, Pan J, Rai SN, Ajkay N, Dragun A, Roberts TL, et al. Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2022;112(1):56\u201365.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16020_CR29","doi-asserted-by":"crossref","unstructured":"Sigaudi V, Zannetti M, Ferrara E, Manfredda I, Mones E, Loi G et al. Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study. Biomedicines. 2022;10(10):2568.","DOI":"10.3390\/biomedicines10102568"},{"issue":"4","key":"16020_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00432-021-03907-w","volume":"148","author":"MA Zerella","year":"2022","unstructured":"Zerella MA, Dicuonzo S, Frassoni S, Zaffaroni M, Gerardi MA, Morra A, et al. Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly\/frail patients treated with 3D and IMRT technique. J Cancer Res Clin Oncol. 2022;148(4):823\u201335.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16020_CR31","first-page":"100651","volume":"41","author":"A Montero","year":"2023","unstructured":"Montero A, Ci\u00e9rvide R, Ca\u00f1adillas C, \u00c1lvarez B, Garc\u00eda-Aranda M, Alonso R, et al. Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer. Clin Transl Radiat Oncol. 2023;41:100651.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"16020_CR32","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/j.clon.2020.11.027","volume":"33","author":"M Machiels","year":"2021","unstructured":"Machiels M, Weytjens R, Bauwens W, Vingerhoed W, Billiet C, Huget P, et al. Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic. Clin Oncol (R Coll Radiol). 2021;33(3):e166\u201371.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"16020_CR33","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1080\/0284186X.2023.2267170","volume":"62","author":"LM Sauvage","year":"2023","unstructured":"Sauvage LM, Loap P, Vu-Bezin J, Cao K, Kissel M, Bringer S, et al. Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre. Acta Oncol. 2023;62(12):1791\u20137.","journal-title":"Acta Oncol"},{"key":"16020_CR34","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/S0960-9776(23)00219-9","volume":"68","author":"MB Rejeb","year":"2023","unstructured":"Rejeb MB, Mezghani M, Moujahed R, Ghorbel L, Hamdoun A, Kochbati L. P102 Ultra hypofractionated radiotherapy after breast conservative surgery: analysis of acute skin toxicity. Breast. 2023;68:S54.","journal-title":"Breast"},{"issue":"2","key":"16020_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijrobp.2025.02.003","volume":"122","author":"M Dzhugashvili","year":"2025","unstructured":"Dzhugashvili M, Serradilla A, Fern\u00e1ndez-Ibiza J, Garc\u00eda G, Malinochka KM, Torres L, et al. Ultrahypofractionation and Simultaneous Integrated Boost in Breast Cancer: Early Side Effects Analysis. Int J Radiat Oncol Biol Phys. 2025;122(2):241\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16020_CR36","doi-asserted-by":"crossref","unstructured":"Wadasadawala DT, Syeda DN, Kenekar DS, Krishnamurthy DR, Sarin DR, Pathak DR, Cumulative risk of cosmetic worsening following ultra hypo-fractionated whole breast radiotherapy with simultaneous integrated boost. : The largest real-world data. Int J Radiat Oncol Biol Phys. 2025;123(3):732\u201341.","DOI":"10.1016\/j.ijrobp.2025.05.061"},{"issue":"5","key":"16020_CR37","doi-asserted-by":"publisher","first-page":"101756","DOI":"10.1016\/j.adro.2025.101756","volume":"10","author":"O Unterkirhere","year":"2025","unstructured":"Unterkirhere O, Streller T, Jeller D, Logaritsch P, Bucher S, Dubsky P, et al. Tolerance of Adjuvant Ultrahypofractionated Whole-Breast Radiation Therapy Employing Moderately Hypofractionated Sequential Boost: A Single Institution Analysis. Adv Radiat Oncol. 2025;10(5):101756.","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"16020_CR38","doi-asserted-by":"publisher","first-page":"101733","DOI":"10.1016\/j.adro.2025.101733","volume":"10","author":"SH Choi","year":"2025","unstructured":"Choi SH, Kim JS, Kim HJ, Park RH, Lee IJ, Kim YB, et al. Volumetric Modulated Arc Therapy for 26 Gy in 5 Fractions Whole Breast Irradiation for Breast Cancer. Adv Radiat Oncol. 2025;10(4):101733.","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"16020_CR39","doi-asserted-by":"publisher","first-page":"104612","DOI":"10.1016\/j.canrad.2025.104612","volume":"29","author":"J Bouziane","year":"2025","unstructured":"Bouziane J, Loap P, Allali S, Cao K, Fourquet A, Kirova Y. Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experience. Cancer Radiother. 2025;29(2):104612.","journal-title":"Cancer Radiother"},{"key":"16020_CR40","doi-asserted-by":"publisher","first-page":"e2400277","DOI":"10.1200\/GO-24-00277","volume":"11","author":"M Fang","year":"2025","unstructured":"Fang M, Gico VC, Casimiro L, Takatsu B, Santos Neto E, Mendoza Lopez RV, et al. Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study. JCO Glob Oncol. 2025;11:e2400277.","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"16020_CR41","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.adro.2024.101668","volume":"10","author":"JT Nicholson","year":"2025","unstructured":"Nicholson JT, Cleary S, Farmer G, Monaghan O, Nugent HOD. Ultrahypofractionated Adjuvant Breast Radiation Therapy (\u00b1\u2009Boost) and Virtual Consultations: Patient Perspectives at 1 Year. Adv Radiat Oncol. 2025;10(1):101668.","journal-title":"Adv Radiat Oncol"},{"issue":"13","key":"16020_CR42","doi-asserted-by":"publisher","first-page":"e7367","DOI":"10.1002\/cam4.7367","volume":"13","author":"A Calvo Tudela","year":"2024","unstructured":"Calvo Tudela A, Garc\u00eda Anaya MJ, Segado Guillot S, Martin Romero N, Lorca Oc\u00f3n MJ, Medina Carmona JA, et al. Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single-institution retrospective cohort series. Cancer Med. 2024;13(13):e7367.","journal-title":"Cancer Med"},{"issue":"4","key":"16020_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12282-024-01577-3","volume":"31","author":"PJK Tokuda","year":"2024","unstructured":"Tokuda PJK, Mitsuyoshi T, Ono Y, Kishi T, Negoro Y, Okumura S, et al. Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study. Breast Cancer. 2024;31(4):643\u20138.","journal-title":"Breast Cancer"},{"issue":"2","key":"16020_CR44","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/j.ijrobp.2024.07.726","volume":"120","author":"I Ratosa","year":"2024","unstructured":"Ratosa I, Montero A, Ciervide R, Alvarez B, Aranda MG, Albarr\u00e1n JV, et al. Ultra-Hypofractionated One-Week Locoregional Radiation for Early Breast Cancer: Dose Distribution to Target Volumes and Organs-at-Risk. Int J Radiation Oncology*Biology*Physics. 2024;120(2):e329\u201330.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"9","key":"16020_CR45","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/j.clon.2024.06.045","volume":"36","author":"MB Ba","year":"2024","unstructured":"Ba MB, Giudici F, Bellini C, Auzac G, Louvel G, Bockel S, et al. Feasibility and Safety of the One-Week Breast Radiation Therapy Program. Clin Oncol (R Coll Radiol). 2024;36(9):e333\u201341.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"16020_CR46","first-page":"611","volume":"16","author":"M Boccardi","year":"2024","unstructured":"Boccardi M, Cilla S, Fanelli M, Romano C, Bonome P, Ferro M, et al. Ultra-Hypofractionated Whole Breast Radiotherapy with Automated Hybrid-VMAT Technique: A Pilot Study on Safety, Skin Toxicity and Aesthetic Outcomes. Breast Cancer (Dove Med Press). 2024;16:611\u20139.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"2, Supplement","key":"16020_CR47","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/j.ijrobp.2024.07.694","volume":"120","author":"H Jing","year":"2024","unstructured":"Jing H, Chen D, Men K, Wang J, Wang S. Early Results of a Prospective Study of Preoperative Tumor-Bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 2024;120(2, Supplement):e314.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"2, Supplement","key":"16020_CR48","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.ijrobp.2024.07.010","volume":"120","author":"S Zheng","year":"2024","unstructured":"Zheng S, Dong M, Jiang J, Zhang J, Shi Y, Gan L et al. Early Safety of Ultra-Hypofractionated Whole Breast Irradiation and Sequential Tumor Bed Boost for Early Breast Cancer (SHIFT): A Multicenter, Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 2024;120(2, Supplement):S16.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"16020_CR49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","volume":"62","author":"GN Marta","year":"2022","unstructured":"Marta GN, Riera R, Pacheco RL, Cabrera Martimbianco AL, Meattini I, Kaidar-Person O, et al. Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials. Breast. 2022;62:84\u201392.","journal-title":"Breast"},{"issue":"1","key":"16020_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13014-020-1463-1","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Yang Y, Guo Q, Ren B, Peng Q, Zou L, et al. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol. 2020;15(1):17.","journal-title":"Radiat Oncol"},{"key":"16020_CR51","doi-asserted-by":"publisher","first-page":"e079089","DOI":"10.1136\/bmj-2023-079089","volume":"386","author":"SF Lee","year":"2024","unstructured":"Lee SF, Kennedy SKF, Caini S, Wong HCY, Yip PL, Poortmans PM, et al. Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis. BMJ. 2024;386:e079089.","journal-title":"BMJ"},{"issue":"1","key":"16020_CR52","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","volume":"23","author":"I Meattini","year":"2022","unstructured":"Meattini I, Becherini C, Boersma L, Kaidar-Person O, Marta GN, Montero A, et al. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022;23(1):e21\u201331.","journal-title":"Lancet Oncol"},{"issue":"4","key":"16020_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00066-020-01744-3","volume":"197","author":"D Krug","year":"2021","unstructured":"Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, et al. Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward. Strahlenther Onkol. 2021;197(4):269\u201380.","journal-title":"Strahlenther Onkol"},{"issue":"11","key":"16020_CR54","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1245\/s10434-021-09777-3","volume":"28","author":"H Eldredge-Hindy","year":"2021","unstructured":"Eldredge-Hindy H, Pan J, Rai SN, Reshko LB, Dragun A, Riley EC, et al. A Phase II Trial of Once Weekly Hypofractionated Breast Irradiation for Early Stage Breast Cancer. Ann Surg Oncol. 2021;28(11):5880\u201392.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"16020_CR55","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.radonc.2010.12.012","volume":"100","author":"C Goldsmith","year":"2011","unstructured":"Goldsmith C, Haviland J, Tsang Y, Sydenham M, Yarnold J. Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? Radiother Oncol. 2011;100(2):236\u201340.","journal-title":"Radiother Oncol"},{"key":"16020_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1748-717X-9-97","volume":"9","author":"P Ciammella","year":"2014","unstructured":"Ciammella P, Podgornii A, Galeandro M, Micera R, Ramundo D, Palmieri T, et al. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors. Radiat Oncol. 2014;9:97.","journal-title":"Radiat Oncol"},{"key":"16020_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1748-717X-7-217","volume":"7","author":"U Kraus-Tiefenbacher","year":"2012","unstructured":"Kraus-Tiefenbacher U, Sfintizky A, Welzel G, Simeonova A, Sperk E, Siebenlist K, et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiat Oncol. 2012;7:217.","journal-title":"Radiat Oncol"},{"key":"16020_CR58","first-page":"100847","volume":"48","author":"JI Choi","year":"2024","unstructured":"Choi JI, Hardy-Abeloos C, Lozano A, Hanlon A, Vargas C, Maduro JH, et al. PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer. Clin Transl Radiat Oncol. 2024;48:100847.","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16020-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:01:52Z","timestamp":1780030912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16020"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16020-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"690"}}